CONTEXT AND OBJECTIVE: Chordoma is a rare tumor with a high risk of locoregional recurrences. The aim of this study was analyze the long-term results from treating this pathological condition.DESIGN AND SETTING: Cohort study in a single hospital in São Paulo, Brazil.METHODS: This was a retrospective cohort study on 42 patients with chordoma who were treated at Hospital A. C. Camargo between 1980 and 2006. The hospital records were reviewed and a descriptive analysis was performed on the clinical-pathological variables. Survival curves were estimated using the Kaplan-Meier method and these were compared using the log-rank test.RESULTS: Nineteen patients were men and 23 were women. Twenty-five tumors (59.5%) were located in the sacrum, eleven...
STUDY DESIGN: Twenty-one cases of chordoma arising in the mobile spine were retrospectively reviewed...
The authors reviewed the files of all patients with chordomas who were admitted and treated at their...
The treatment of clival chordomas remains challenging. Total tumour resection is often impossible wi...
INTRODUCTION: Chordoma is a rare and slow-growing tumor, with local aggressiveness and preferential ...
STUDY DESIGN: Retrospective case series. OBJECTIVE: To report on the natural history and long...
AIM: To discuss the optimal and recent treatment options based on clinical review of 16 chordoma pat...
STUDY DESIGN: A consecutive series of 52 chordomas of the mobile spine observed over a 50-year perio...
© 2017 Hong Kong College of Radiologists. Objectives: To report the clinical characteristics, treatm...
STUDY DESIGN: Retrospective case series. OBJECTIVE: To report the outcome of a series of patients wi...
BACKGROUND: Chordomas are rare bone tumors arising from remnants of the embryonic notochord. METHODS...
Chordoma is a slow growing cancer of tissue found inside the spine. Chordoma can happen anywhere alo...
Background: Chordoma is the most common primary malignant tumor of the spine. It is extremely rare a...
Objectives Skull base chordomas are locally aggressive malignant tumors derived from the notochord ...
Background and objectives: The best treatment of sacral chordoma is surgical resection, nowadays ass...
Introduction:Skull base chordomas are rare neoplasms arising from the notochord.Although histologica...
STUDY DESIGN: Twenty-one cases of chordoma arising in the mobile spine were retrospectively reviewed...
The authors reviewed the files of all patients with chordomas who were admitted and treated at their...
The treatment of clival chordomas remains challenging. Total tumour resection is often impossible wi...
INTRODUCTION: Chordoma is a rare and slow-growing tumor, with local aggressiveness and preferential ...
STUDY DESIGN: Retrospective case series. OBJECTIVE: To report on the natural history and long...
AIM: To discuss the optimal and recent treatment options based on clinical review of 16 chordoma pat...
STUDY DESIGN: A consecutive series of 52 chordomas of the mobile spine observed over a 50-year perio...
© 2017 Hong Kong College of Radiologists. Objectives: To report the clinical characteristics, treatm...
STUDY DESIGN: Retrospective case series. OBJECTIVE: To report the outcome of a series of patients wi...
BACKGROUND: Chordomas are rare bone tumors arising from remnants of the embryonic notochord. METHODS...
Chordoma is a slow growing cancer of tissue found inside the spine. Chordoma can happen anywhere alo...
Background: Chordoma is the most common primary malignant tumor of the spine. It is extremely rare a...
Objectives Skull base chordomas are locally aggressive malignant tumors derived from the notochord ...
Background and objectives: The best treatment of sacral chordoma is surgical resection, nowadays ass...
Introduction:Skull base chordomas are rare neoplasms arising from the notochord.Although histologica...
STUDY DESIGN: Twenty-one cases of chordoma arising in the mobile spine were retrospectively reviewed...
The authors reviewed the files of all patients with chordomas who were admitted and treated at their...
The treatment of clival chordomas remains challenging. Total tumour resection is often impossible wi...